PHMD News Alert Photomedex (PHMD) 1.68 02/14/2015 00:41:14

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:41 AM

Photomedex (PHMD) 1.68 $PHMD

Dermatology Devices Market worth $11,337.0 Million by 2019
M2 - Thu Feb 12, 8:19AM CST
"Major Players of Dermatology Devices Market are Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Genesis Biosystems, Inc. (U.S.), HEINE Optotechnik GmbH & Co. KG (Germany), Lumenis Ltd. (Israel), Michelson Diagnostics (U.K.), PhotoMedex, Inc. (U.S.), and Solta Medical, Inc. (U.S.)"The report segments the global dermatology devices market on the basis of applications, products, and geographies. he report provides a granular understanding of the dermatology devices market.
CYNO: 31.37 (+0.80), LMNS: 10.80 (+0.57), PHMD: 1.68 (+0.04)

PhotoMedex jettisons LCA-Vision
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:01PM CST

PHMD: 1.68 (+0.04)

PhotoMedex Sells LCA-Vision Subsidiary to Vision Acquisition, LLC for $40 Million
Business Wire - Mon Feb 02, 1:55PM CST
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) (the "Company"

announces the sale of its LCA-Vision subsidiary to Vision Acquisition, LLC for $40 million in cash. Excluding working capital adjustments and professional fees, PhotoMedex will realize net proceeds of approximately $35.3 million. The Company's secured creditors as well as its board of directors have approved this transaction, which closed effective as of January 31, 2015. LCA-Vision operates 59 LasikPlus(R) vision centers in the U.S., including 51 full-service LasikPlus fixed-site laser vision correction centers and eight pre- and post-operative LasikPlus(R) satellite centers.
PHMD: 1.68 (+0.04)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 11:46AM CST

HTBX: 5.83 (+0.22), NES: 3.52 (+0.13), TEAR: 2.15 (+0.03), FENG: 7.92 (+0.23), OCN: 9.10 (+0.09), STX: 61.83 (+0.67), LACO: 8.38 (+0.17), PHMD: 1.68 (+0.04), BBEP: 7.85 (+0.32), HGSH: 3.05 (-0.13), MBT: 10.36 (+0.62), NBG: 1.61 (+0.18), NDRM: 10.76 (+0.22), PT: 0.83 (+0.04), POST: 48.62 (-0.25), ATNM: 3.60 (-0.29), MWV: 53.91 (+0.59), WRES: 1.27 (+0.01), IDN: 1.43 (-0.01), KONE: 4.20 (+0.03)

PhotoMedex: Declining Sales, Legal Issues, And Now A Stock Promotion
Hunter Straus - at Seeking Alpha - Sun Jan 18, 11:38PM CST

PHMD: 1.68 (+0.04)

Premarket Gainers/Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 8:24AM CST

ANV: 0.97 (-0.03), ALX: 453.22 (-6.93), PCYC: 163.28 (+0.23), NLST: 1.86 (unch), ECOM: 9.69 (+0.63), VLCCF: 4.15 (-0.06), PHMD: 1.68 (+0.04), BNCL: 11.54 (-0.02), GURE: 1.64 (-0.04), CTIC: 2.23 (-0.02), AUY: 4.13 (+0.13), ATRS: 2.45 (+0.05)

5 Stocks Under $10 Setting Up to Trade Higher: Callon Petroleum and More
at The Street - Fri Jan 09, 9:32AM CST
These setups often produce monster moves higher in very short time frames.
ACRX: 7.29 (-0.06), NOG: 8.76 (+0.38), CPE: 7.37 (+0.27), PHMD: 1.68 (+0.04), NKA: 1.68 (+0.13)

Turnaround potential? 2014's worst performers in the Russell 2000
Seeking Alpha - at Seeking Alpha - Sun Jan 04, 2:49PM CST

KWK: 0.15 (unch), BPZ: 0.25 (unch), EXXI: 4.00 (+0.42), MBII: 3.88 (+0.33), MILL: 2.07 (+0.09), PHMD: 1.68 (+0.04), PRKR: 1.07 (+0.04), RLOC: 3.58 (+0.42), NTLS: 5.19 (+0.05), VTG: 0.52 (-0.02), GDP: 3.58 (+0.29), REN: 1.14 (unch), CYTX: 0.47 (unch), XONE: 16.93 (-0.16), KEG: 2.14 (+0.08), REXX: 5.08 (+0.13), AMZG: 0.65 (-0.03), COVS: 2.47 (+0.11), EXEL: 2.48 (+0.20), ANV: 0.97 (-0.03), VRNG: 0.81 (+0.01), FUEL: 14.30 (+0.65), ZQK: 2.26 (+0.05), GALT: 3.84 (+0.16), EOX: 1.15 (unch), SALT: 2.17 (+0.18), MM: 1.67 (+0.07), WLT: 1.09 (+0.05), NADL: 2.10 (-0.02), QRHC: 1.30 (+0.03), MCP: 0.97 (+0.04), ANR: 1.27 (+0.03), ARO: 3.63 (+0.04), RGDO: 1.17 (+0.02), HERO: 0.92 (+0.02), FWM: 5.55 (+0.08), CONN: 24.69 (-0.07), MPO: 1.00 (-0.02), CVEO: 3.87 (+0.15), SZYM: 2.64 (+0.02)

Where Investors Are Going: Complementary Research on Volcano, Rite Aid, Carnival Corporation, PhotoMedex and Joy Global
PR Newswire - Thu Dec 18, 8:53AM CST
Moments ago, Realtime Equities released new analyst updates concerning several important developing situations including Volcano (NASDAQ: VOLC), Rite Aid (NYSE: RAD), Carnival Corporation (NYSE: CCL), PhotoMedex (NASDAQ: PHMD), and Joy Global (NYSE: JOY). Realtime Equities is the leader in realtime news, commentary and analysis - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
JOY: 44.14 (+0.35), CCL: 43.48 (-0.89), VOLC: 17.98 (+0.03), PHMD: 1.68 (+0.04), RAD: 8.34 (+0.25)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 16, 8:10AM CST

FRO: 2.96 (+0.07), TLM: 7.63 (-0.03), PHMD: 1.68 (+0.04), SLXP: 152.35 (+3.17), BBEP: 7.85 (+0.32), EXAS: 25.56 (-0.54), NVGN: 2.79 (+0.17), MBT: 10.36 (+0.62), LPI: 13.25 (+0.81), CYCC: 0.62 (-0.01), GOL: 3.85 (+0.01), AUY: 4.13 (+0.13), ORAN: 18.52 (+0.07), YNDX: 17.00 (+0.59)

The long slide of PhotoMedex continues
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 12:15PM CST

PHMD: 1.68 (+0.04)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 4:42PM CST

VNET: 19.05 (+0.95), VEEV: 30.12 (+0.17), IQNT: 17.96 (-0.31), CPE: 7.37 (+0.27), AVAV: 26.86 (+0.37), UCI: 16.19 (+0.19), ANGI: 5.02 (+0.12), BLOX: 20.49 (+0.82), PHMD: 1.68 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....